WMSA
ENZN

Weiss Multi-Strategy Advisers’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-67,114
Closed -$78K – 1221
2013
Q4 		$78K Buy
+67,114
New +$103K ﹤0.01% 953

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ENZN Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2014, closing a stake of 67,114 shares — an estimated $78K sold.

Weiss Multi-Strategy Advisers first reported a position in ENZN in Q4 2013 and held it in 1 quarter. The position peaked at $78K in Q4 2013. 75 funds tracked by Wall St. Rank hold ENZN as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 67,114 ENZON PHARMACEUTICALS INC shares in Q1 2014, an estimated $78K.
  • Weiss Multi-Strategy Advisers first reported a position in ENZON PHARMACEUTICALS INC in Q4 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's ENZON PHARMACEUTICALS INC position peaked at $78K in Q4 2013.
  • 75 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.